According to our (Global Info Research) latest study, the global Transurethral Prostatic Resection Device market size was valued at US$ 1454 million in 2025 and is forecast to a readjusted size of US$ 2049 million by 2032 with a CAGR of 5.1% during review period.
A transurethral resection of the prostate (TURP) is a surgical procedure that involves cutting away a section of the prostate. The prostate is a small gland in the pelvis only found in men. It"s located between the penis and bladder, and surrounds the urethra (the tube that carries urine from the bladder to the penis).
The global transurethral prostatic resection device market refers to the industry that provides medical devices used in transurethral resection of the prostate (TURP) procedures. TURP is a minimally invasive surgical procedure performed to treat benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland. Here’s an overview of the market:
Market Overview: The transurethral prostatic resection device market has witnessed significant growth due to the increasing prevalence of BPH and the rising demand for minimally invasive treatment options. TURP is a widely accepted and effective procedure for relieving urinary symptoms associated with BPH, and the demand for TURP devices is driven by the growing patient population and advancements in technology.
Procedure and Device: TURP involves the removal of excess prostate tissue using a resectoscope, which is a specialized instrument inserted through the urethra. The resectoscope typically consists of a sheath, a working element with an electrode, and an irrigation system. During the procedure, the resectoscope allows the surgeon to remove the obstructing prostate tissue and cauterize bleeding vessels.
Types of TURP Devices: The market offers a variety of TURP devices, including monopolar and bipolar resectoscopes. Monopolar resectoscopes use an electrical current to cut and cauterize tissue, while bipolar resectoscopes pass the electrical current through the saline irrigation fluid, reducing the risk of complications associated with monopolar devices. Other types of TURP devices may include continuous flow resectoscopes and laser resectoscopes, which offer alternative methods for performing the procedure.
Market Players: The market for transurethral prostatic resection devices is competitive and comprises various medical device manufacturers. Key market players may include leading medical technology companies and specialized manufacturers that provide a range of TURP devices. These companies focus on product innovation, safety, and efficiency to meet the needs of healthcare professionals performing TURP procedures.
Market Dynamics: The market is driven by factors such as the increasing prevalence of BPH, technological advancements in TURP devices, a growing elderly population, and the demand for minimally invasive procedures. Additionally, rising awareness about the benefits of TURP over traditional open surgeries, such as shorter hospital stays and faster recovery, contributes to the market growth.
Regional Markets: The global transurethral prostatic resection device market is segmented into various regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe have a significant market share due to the high prevalence of BPH and the availability of advanced healthcare facilities. The market in Asia Pacific is expected to witness substantial growth due to the increasing aging population and improving healthcare infrastructure in the region.
Regulatory Landscape: The transurethral prostatic resection device market is subject to various regulatory and quality standards set by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must comply with these regulations to ensure the safety and effectiveness of their devices.
Market Outlook: The global transurethral prostatic resection device market is projected to grow in the coming years, driven by the increasing prevalence of BPH, advancements in TURP technology, and the growing adoption of minimally invasive procedures. However, factors such as the availability of alternative treatment options and the high cost of TURP devices may pose challenges to market growth.
This report is a detailed and comprehensive analysis for global Transurethral Prostatic Resection Device market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transurethral Prostatic Resection Device market size and forecasts, in consumption value ($ Million), 2021-2032
Global Transurethral Prostatic Resection Device market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Transurethral Prostatic Resection Device market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Transurethral Prostatic Resection Device market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transurethral Prostatic Resection Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transurethral Prostatic Resection Device market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Wellspect HealthCare, Manfred Sauer, Teleflex, Hollister, Boston Scientific, Karl Storz, Olympus, Lumenis, Covidien, Cook Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Transurethral Prostatic Resection Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monopolar TURP
Bipolar TURP
Market segment by Application
Benign Prostate Hyperplasia
Urinary Tract Infection
Erectile Dysfunction
Others
Market segment by players, this report covers
Wellspect HealthCare
Manfred Sauer
Teleflex
Hollister
Boston Scientific
Karl Storz
Olympus
Lumenis
Covidien
Cook Medical
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transurethral Prostatic Resection Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transurethral Prostatic Resection Device, with revenue, gross margin, and global market share of Transurethral Prostatic Resection Device from 2021 to 2026.
Chapter 3, the Transurethral Prostatic Resection Device competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Transurethral Prostatic Resection Device market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transurethral Prostatic Resection Device.
Chapter 13, to describe Transurethral Prostatic Resection Device research findings and conclusion.
Summary:
Get latest Market Research Reports on Transurethral Prostatic Resection Device. Industry analysis & Market Report on Transurethral Prostatic Resection Device is a syndicated market report, published as Global Transurethral Prostatic Resection Device Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Transurethral Prostatic Resection Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.